KH001 / HysensBio - LARVOL DELTA

Phase 2 Study of KH001 in Long-term Relief From Dentin Hypersensitivity (clinicaltrials.gov) - P2 | N=120 | Completed | Sponsor: HysensBio Co., Ltd | Active, not recruiting ➔ Completed

Trial completion • Immunology

A Study to Evaluate Physiologic Dentin Regeneration and Safety of KH001 in the Administration of Erupted Wisdom Tooth With Dentin Caries (clinicaltrials.gov) - P2 | N=12 | Completed | Sponsor: Byoung-Moo Seo | Not yet recruiting ➔ Completed

Trial completion

Phase 2 Study of KH001 in Long-term Relief From Dentin Hypersensitivity (clinicaltrials.gov) - P2 | N=120 | Active, not recruiting | Sponsor: HysensBio Co., Ltd | Recruiting ➔ Active, not recruiting | Trial completion date: Jun 2025 ➔ Dec 2025 | Trial primary completion date: Feb 2025 ➔ Dec 2025

Enrollment closed • Trial completion date • Trial primary completion date • Immunology

KH-001-D201: A Study to Evaluate the Efficacy and Safety of KH001 in Patients with Dentin Hypersensitivity (clinicaltrials.gov) - P2 | N=171 | Completed | Sponsor: HysensBio Co., Ltd | Recruiting ➔ Completed

Trial completion • Immunology

Phase 2 Study of KH001 in Long-term Relief from Dentin Hypersensitivity (clinicaltrials.gov) - P2 | N=120 | Recruiting | Sponsor: HysensBio Co., Ltd | Not yet recruiting ➔ Recruiting

Enrollment open • Immunology

A Study to Evaluate Physiologic Dentin Regeneration and Safety of KH001 in the Administration of Erupted Wisdom Tooth With Dentin Caries (clinicaltrials.gov) - P2 | N=12 | Not yet recruiting | Sponsor: Byoung-Moo Seo

New P2 trial

Phase 2 Study of KH001 in Long-term Relief From Dentin Hypersensitivity (clinicaltrials.gov) - P2 | N=120 | Not yet recruiting | Sponsor: HysensBio Co., Ltd

New P2 trial • Immunology

KH-001-D201: A Study to Evaluate the Efficacy and Safety of KH001 in Patients With Dentin Hypersensitivity (clinicaltrials.gov) - P2 | N=171 | Recruiting | Sponsor: HysensBio Co., Ltd | Not yet recruiting ➔ Recruiting

Enrollment open • Immunology

KH-001-D201: A Study to Evaluate the Efficacy and Safety of KH001 in Patients With Dentin Hypersensitivity (clinicaltrials.gov) - P2 | N=171 | Not yet recruiting | Sponsor: HysensBio Co., Ltd

New P2 trial • Immunology

Evaluation of the Safety and Tolerability of KH001 in Dentin Hypersensitivity Patients (clinicaltrials.gov) - P1/2 | N=40 | Completed | Sponsor: HysensBio Co., Ltd | Recruiting ➔ Completed | Trial completion date: Dec 2023 ➔ Aug 2023 | Trial primary completion date: Nov 2023 ➔ Mar 2023

Trial completion • Trial completion date • Trial primary completion date • Immunology

Evaluation of the Safety and Tolerability of KH001 in Dentin Hypersensitivity Patients (clinicaltrials.gov) - P1/2 | N=40 | Recruiting | Sponsor: HysensBio Co., Ltd | Trial completion date: Mar 2023 ➔ Dec 2023 | Trial primary completion date: Jan 2023 ➔ Nov 2023

Trial completion date • Trial primary completion date • Immunology